Print

Print


Here is another example of the fall out related to the honesty of research.




Subject: Stem cell editorial

Bernie:

An editorial from the San Francisco Chronicle (today):

-------------------------------------------------------------------

Stem-cell politics
-
Friday, January 13, 2006


THE TRAGIC RISE and fall of veterinarian Hwang Woo Suk, the South
Korean stem-cell researcher who was found to have fabricated his purported
breakthroughs in stem-cell science (except for the cloning of the Afghan
hound puppy Snuppy), offers California a cautionary tale. If legal cases
blocking Proposition 71 bond funds are resolved, California taxpayers will
be
funding embryonic stem-cell research where expectations of cures are high
and a lucrative new life-science industry is promised.

What is to prevent similar fraud and ethical lapses from happening here in
California, where voters agreed to spend $3 billion on stem-cell research?

"Scientists," responded Zach Hall, president of the California Institute for

Regenerative Medicine, the funding entity created by Prop. 71. Warning that
every industry has the potential for an Enron, Hall touted the American
system of peer review as the best way to expose rogue scientists and bad
science and to keep research-funding decisions apart from undue political,
religious or geographic influences. "What will not stop this from happening
is
government oversight," he said.

In a world of "pure" science, maybe. But stem-cell research is, at this
point,
anything but pure. Scientists rail about the "political" interference in
their
work by the religious-right aligned Bush administration, but what was the
campaign launched by the stem-cell research proponents to sell the stem-cell

bonds, if not political? With business and political capital -- not to
mention
the state's image as a technological innovator -- on the line, the stem-cell

institute needs oversight, both regulatory and scientific.

A 19-member committee of the institute, which has been working on ethical
standards and research safeguards since January 2005, will present its draft
to
the institute's governing body on Feb. 10. Even though the committee met
four times and held three public hearings to craft these potential state
regulations that will guide funding, caution is in order.

Questions remain about the sourcing of the human eggs and about which
avenues of research are best pursued with the taxpayers' money. Would voters

embrace research that might require hundreds of human eggs to produce a
therapy for a single person? If these rules are adopted, who enforces them?
Are there punishments for infractions?

These matters of great public concern should be subject to government
regulation -- especially when taxpayers are picking up the
multi-billion-dollar
tab for this research.



----------------------------------------------------------------------------
----
C2006 San Francisco Chronicle


=======================================

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn